APA (7th ed.) Citation

Zou, X., Chen, W., Zhang, G., Ke, H., Yang, Q., & Li, X. (2021). Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Zou, Xue-lin, Wei-yong Chen, Guang-yan Zhang, Hua Ke, Qiu-hong Yang, and Xiao-bo Li. Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Zou, Xue-lin, et al. Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors. Frontiers Media S.A, 2021.